MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Impairment of REM Sleep Architecture: A Potential Biomarker for Parkinson’s Progression

    A. Mirzazadeh, R. Levy, H. Rahul, R. Dorsey, A. Videnovic, D. Katabi (Cambridge, USA)

    Objective: Our study finds that the effects of Parkinson’s disease on impairing normal REM sleep far surpass those of the RBD subpopulation alone. In fact,…
  • 2024 International Congress

    Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

    C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)

    Objective: To compare the gastrointestinal dysfunction in patients with early-onset Parkinson’s disease (EOPD) and late-onset Parkinson’s disease (LOPD). Background: Gastrointestinal dysfunction is one of the…
  • 2024 International Congress

    Aberrant connectivity in Resting-State Brain Networks Underlying Neuropsychiatric Symptoms in Prodromal Lewy Body Dementia.

    L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, H. Sigurdsson, J. Schumacher, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: This study aimed to determine the functional neural correlates of neuropsychiatric symptoms (NPS), including mood disorders, anxiety and psychosis, in prodromal Lewy body dementia (LBD)…
  • 2024 International Congress

    Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

    K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)

    Objective: To evaluate cognitive decline in people living with PD (PwP), to determine to which degree different neuropsychiatric symptoms are risk factors for cognitive decline…
  • 2024 International Congress

    Psychotic features in patients with Parkinson’s disease

    S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The objective of the study was to assess the psychotic symptoms associated with Parkinson's disease (PD) and to establish statistical correlations with sociodemographic and…
  • 2024 International Congress

    The Role of Cortisol a Mediator in Influencing Cognitive Function

    DT. Akramova (Tashkent, Uzbekistan)

    Objective: To explore cortisol's impact on cognitive decline and life quality in Parkinson's disease (PD) Background: PD patients exhibit varied symptoms, including cognitive deficits and…
  • 2024 International Congress

    Case Report: Carbamazepine-Induced Dystonia, Tremor and Negative Myoclonus

    D. Ouhabi, H. Naciri Darai, H. Tibar, W. Regragui (Rabat, Morocco)

    Objective: The objective of this case presentation is mainly to raise awareness of possible side effects of Carbamazepine in epileptic and non-epileptic patients, even years…
  • 2024 International Congress

    Prevalence of Tic Disorder in School Children of Northern India

    S. Lavania, A. Pattojoshi, AH. Khan (Agra, India)

    Objective: To know the prevalence of Tic Disorder (TD) in the school children of Tundla district in northern India and to find out the association between…
  • 2024 International Congress

    Gender Differences in Physical Activity in Parkinson’s Disease

    G. Vitek, M. Fullard (Aurora, USA)

    Objective: Examine gender differences in physical activity in different stages of Parkinson’s disease (PD). Background: Physical activity has been linked to slower progression and improvement…
  • 2024 International Congress

    Time To Rethink the Measurement of Tremor in Early-Stage Parkinson’s Disease

    N. Massat, F. La Gamba, M. Key Prato, T. Morel (Slough, United Kingdom)

    Objective: To assess if MDS-UPDRS Part III tremor items may form a suitable subscale in early-stage PD. Background: Symptoms of tremor are highly meaningful to…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley